Steroid-induced dysglycaemia in patients with haematological disorders a ten-year review in a tertiary hospital in Ghana

Dei-Adomakoh, Yvonne; Akpalu, Josephine; Yawson, Alfred E.; Ekem5, Ivy; Atiase, Yacoba

dc.contributor.author	Dei-Adomakoh, Yvonne
dc.contributor.author	Akpalu, Josephine
dc.contributor.author	Yawson, Alfred E.
dc.contributor.author	Ekem5, Ivy
dc.contributor.author	Atiase, Yacoba
dc.date.accessioned	2021-03-26T12:17:50Z
dc.date.available	2021-03-26T12:17:50Z
dc.date.issued	2019-06
dc.identifier.uri	http://hdl.handle.net/123456789/5191
dc.description.abstract	Background: Glucocorticoids (steroids) play a key role in the management of multiple medical conditions including haematological disorders. This study looked at the prevalence of steroid induced dysglycaemia in patients with haematological disorders receiving steroids as part of their treatment with the view of modifying its use and selection of patients where necessary.	en_US
dc.language.iso	en	en_US
dc.subject	steroids	en_US
dc.subject	haematological disorders	en_US
dc.subject	dysglycaemia	en_US
dc.subject	risk factors	en_US
dc.title	Steroid-induced dysglycaemia in patients with haematological disorders a ten-year review in a tertiary hospital in Ghana	en_US
dc.type	Article	en_US